These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 8672431

  • 1. Identification of amino acid residues in transmembrane helices VI and VII of the lutropin/choriogonadotropin receptor involved in signaling.
    Fernandez LM, Puett D.
    Biochemistry; 1996 Apr 02; 35(13):3986-93. PubMed ID: 8672431
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification of two amino acid residues on the extracellular domain of the lutropin/choriogonadotropin receptor important in signaling.
    Huang J, Puett D.
    J Biol Chem; 1995 Dec 15; 270(50):30023-8. PubMed ID: 8530405
    [Abstract] [Full Text] [Related]

  • 4. Evidence for an important functional role of intracellular loop II of the lutropin receptor.
    Fernandez LM, Puett D.
    Mol Cell Endocrinol; 1997 Apr 04; 128(1-2):161-9. PubMed ID: 9140087
    [Abstract] [Full Text] [Related]

  • 5. Characterization of a region of the lutropin receptor extracellular domain near transmembrane helix 1 that is important in ligand-mediated signaling.
    Alvarez CA, Narayan P, Huang J, Puett D.
    Endocrinology; 1999 Apr 04; 140(4):1775-82. PubMed ID: 10098515
    [Abstract] [Full Text] [Related]

  • 6. Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling.
    Bhowmick N, Huang J, Puett D, Isaacs NW, Lapthorn AJ.
    Mol Endocrinol; 1996 Sep 04; 10(9):1147-59. PubMed ID: 8885249
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The C-terminal third of the human luteinizing hormone (LH) receptor is important for inositol phosphate release: analysis using chimeric human LH/follicle-stimulating hormone receptors.
    Hirsch B, Kudo M, Naro F, Conti M, Hsueh AJ.
    Mol Endocrinol; 1996 Sep 04; 10(9):1127-37. PubMed ID: 8885247
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reconstitution of a high-affinity functional lutropin receptor by coexpression of its extracellular and membrane domains.
    Remy JJ, Bozon V, Couture L, Goxe B, Salesse R, Garnier J.
    Biochem Biophys Res Commun; 1993 Jun 30; 193(3):1023-30. PubMed ID: 8391796
    [Abstract] [Full Text] [Related]

  • 12. Interaction, signal generation, signal divergence, and signal transduction of LH/CG and the receptor.
    Ji TH, Ryu KS, Gilchrist R, Ji I.
    Recent Prog Horm Res; 1997 Jun 30; 52():431-53; discussion 454. PubMed ID: 9238862
    [Abstract] [Full Text] [Related]

  • 13. Cloning and functional expression of the equine luteinizing hormone/chorionic gonadotrophin receptor.
    Saint-Dizier M, Foulon-Gauze F, Lecompte F, Combarnous Y, Chopineau M.
    J Endocrinol; 2004 Dec 30; 183(3):551-9. PubMed ID: 15590981
    [Abstract] [Full Text] [Related]

  • 14. Phe576 plays an important role in the secondary structure and intracellular signaling of the human luteinizing hormone/chorionic gonadotropin receptor.
    Yano K, Kohn LD, Saji M, Okuno A, Cutler GB.
    J Clin Endocrinol Metab; 1997 Aug 30; 82(8):2586-91. PubMed ID: 9253338
    [Abstract] [Full Text] [Related]

  • 15. Pleiotropic effects of substitutions of a highly conserved leucine in transmembrane helix III of the human lutropin/choriogonadotropin receptor with respect to constitutive activation and hormone responsiveness.
    Shinozaki H, Fanelli F, Liu X, Jaquette J, Nakamura K, Segaloff DL.
    Mol Endocrinol; 2001 Jun 30; 15(6):972-84. PubMed ID: 11376115
    [Abstract] [Full Text] [Related]

  • 16. Deletions of portions of the extracellular loops of the lutropin/choriogonadotropin receptor decrease the binding affinity for ovine luteinizing hormone, but not human choriogonadotropin, by preventing the formation of mature cell surface receptor.
    Abell A, Liu X, Segaloff DL.
    J Biol Chem; 1996 Feb 23; 271(8):4518-27. PubMed ID: 8626807
    [Abstract] [Full Text] [Related]

  • 17. Altered ligand dissociation rates in thyrotropin-releasing hormone receptors mutated in glutamine 105 of transmembrane helix III.
    del Camino D, Barros F, Pardo LA, de la Peña P.
    Biochemistry; 1997 Mar 18; 36(11):3308-18. PubMed ID: 9116009
    [Abstract] [Full Text] [Related]

  • 18. Thyrotropin, like luteinizing hormone (LH) and chorionic gonadotropin (CG), increases cAMP and inositol phosphate levels in cells with recombinant human LH/CG receptor.
    Hidaka A, Minegishi T, Kohn LD.
    Biochem Biophys Res Commun; 1993 Oct 15; 196(1):187-95. PubMed ID: 8216292
    [Abstract] [Full Text] [Related]

  • 19. Identification of regions in the human angiotensin II receptor type 1 responsible for Gi and Gq coupling by mutagenesis study.
    Shibata T, Suzuki C, Ohnishi J, Murakami K, Miyazaki H.
    Biochem Biophys Res Commun; 1996 Jan 05; 218(1):383-9. PubMed ID: 8573166
    [Abstract] [Full Text] [Related]

  • 20. Exoloop 3 of the luteinizing hormone/choriogonadotropin receptor. Lys583 is essential and irreplaceable for human choriogonadotropin (hCG)-dependent receptor activation but not for high affinity hCG binding.
    Ryu KS, Gilchrist RL, Ji I, Kim SJ, Ji TH.
    J Biol Chem; 1996 Mar 29; 271(13):7301-4. PubMed ID: 8631747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.